
2.17 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.65 Today|||52-Week Range 3.78 | -32.40% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.70, with a high estimate of 7.00 and a low estimate of 2.40. The median estimate represents a +116.59% increase from the last price of 2.17.
The current consensus among 4 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.